185 related articles for article (PubMed ID: 9823299)
1. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays.
Khan J; Simon R; Bittner M; Chen Y; Leighton SB; Pohida T; Smith PD; Jiang Y; Gooden GC; Trent JM; Meltzer PS
Cancer Res; 1998 Nov; 58(22):5009-13. PubMed ID: 9823299
[TBL] [Abstract][Full Text] [Related]
2. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3.
Fredericks WJ; Galili N; Mukhopadhyay S; Rovera G; Bennicelli J; Barr FG; Rauscher FJ
Mol Cell Biol; 1995 Mar; 15(3):1522-35. PubMed ID: 7862145
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional studies of FKHR-PAX3, a reciprocal fusion gene of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma.
Hu Q; Yuan Y; Wang C
PLoS One; 2013; 8(6):e68065. PubMed ID: 23799156
[TBL] [Abstract][Full Text] [Related]
4. Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?
Anderson J; Gordon T; McManus A; Mapp T; Gould S; Kelsey A; McDowell H; Pinkerton R; Shipley J; Pritchard-Jones K;
Br J Cancer; 2001 Sep; 85(6):831-5. PubMed ID: 11556833
[TBL] [Abstract][Full Text] [Related]
5. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.
Sublett JE; Jeon IS; Shapiro DN
Oncogene; 1995 Aug; 11(3):545-52. PubMed ID: 7630639
[TBL] [Abstract][Full Text] [Related]
6. Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma.
Davis RJ; Barr FG
Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8047-51. PubMed ID: 9223312
[TBL] [Abstract][Full Text] [Related]
7. Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1.
Wachtel M; Dettling M; Koscielniak E; Stegmaier S; Treuner J; Simon-Klingenstein K; Bühlmann P; Niggli FK; Schäfer BW
Cancer Res; 2004 Aug; 64(16):5539-45. PubMed ID: 15313887
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic analysis consistently identifies translocations involving chromosomes 1, 2 and 15 in five embryonal rhabdomyosarcoma cell lines and a PAX-FOXO1A fusion gene negative alveolar rhabdomyosarcoma cell line.
Roberts I; Gordon A; Wang R; Pritchard-Jones K; Shipley J; Coleman N
Cytogenet Cell Genet; 2001; 95(3-4):134-42. PubMed ID: 12063389
[TBL] [Abstract][Full Text] [Related]
9. Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains.
Bennicelli JL; Fredericks WJ; Wilson RB; Rauscher FJ; Barr FG
Oncogene; 1995 Jul; 11(1):119-30. PubMed ID: 7624119
[TBL] [Abstract][Full Text] [Related]
10. Normal and rearranged PAX3 expression in human rhabdomyosarcoma.
Frascella E; Toffolatti L; Rosolen A
Cancer Genet Cytogenet; 1998 Apr; 102(2):104-9. PubMed ID: 9546061
[TBL] [Abstract][Full Text] [Related]
11. Detection of FOXO1 (FKHR) gene break-apart by fluorescence in situ hybridization in formalin-fixed, paraffin-embedded alveolar rhabdomyosarcomas and its clinicopathologic correlation.
Mehra S; de la Roza G; Tull J; Shrimpton A; Valente A; Zhang S
Diagn Mol Pathol; 2008 Mar; 17(1):14-20. PubMed ID: 18303411
[TBL] [Abstract][Full Text] [Related]
12. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene.
Khan J; Bittner ML; Saal LH; Teichmann U; Azorsa DO; Gooden GC; Pavan WJ; Trent JM; Meltzer PS
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13264-9. PubMed ID: 10557309
[TBL] [Abstract][Full Text] [Related]
13. RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
Thomson B; Hawkins D; Felgenhauer J; Radich J
Bone Marrow Transplant; 1999 Sep; 24(5):527-33. PubMed ID: 10482938
[TBL] [Abstract][Full Text] [Related]
14. Translin recognition site sequences flank chromosome translocation breakpoints in alveolar rhabdomyosarcoma cell lines.
Chalk JG; Barr FG; Mitchell CD
Oncogene; 1997 Sep; 15(10):1199-205. PubMed ID: 9294613
[TBL] [Abstract][Full Text] [Related]
15. New genetic tactics to model alveolar rhabdomyosarcoma in the mouse.
Keller C; Capecchi MR
Cancer Res; 2005 Sep; 65(17):7530-2. PubMed ID: 16140913
[TBL] [Abstract][Full Text] [Related]
16. Structural characterization of the FKHR gene and its rearrangement in alveolar rhabdomyosarcoma.
Davis RJ; Bennicelli JL; Macina RA; Nycum LM; Biegel JA; Barr FG
Hum Mol Genet; 1995 Dec; 4(12):2355-62. PubMed ID: 8634710
[TBL] [Abstract][Full Text] [Related]
17. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma.
Galili N; Davis RJ; Fredericks WJ; Mukhopadhyay S; Rauscher FJ; Emanuel BS; Rovera G; Barr FG
Nat Genet; 1993 Nov; 5(3):230-5. PubMed ID: 8275086
[TBL] [Abstract][Full Text] [Related]
18. Fusions involving paired box and fork head family transcription factors in the pediatric cancer alveolar rhabdomyosarcoma.
Barr FG
Curr Top Microbiol Immunol; 1997; 220():113-29. PubMed ID: 9103678
[No Abstract] [Full Text] [Related]
19. Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma.
Bennicelli JL; Edwards RH; Barr FG
Proc Natl Acad Sci U S A; 1996 May; 93(11):5455-9. PubMed ID: 8643596
[TBL] [Abstract][Full Text] [Related]
20. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.
Davis RJ; D'Cruz CM; Lovell MA; Biegel JA; Barr FG
Cancer Res; 1994 Jun; 54(11):2869-72. PubMed ID: 8187070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]